Biocardia Inc (BCDA): Congress and insider trades
Who in Congress and inside the company traded BCDA, when each filing appeared, and what buying after each one would have earned against the S&P 500.
Key Facts
- Biocardia Inc (BCDA) is a listed stock on NASDAQ.
- Insiders filed 24 open market buys worth $149K and 0 sells worth $0, the latest filed 2026-09-23 (23 September 2026).
- Across 7 scored buys, Insiders averaged -8.7% against the S&P 500 (SPY) over the 90 days after disclosure, with 29% of them ahead of the index. That result is too few trades to draw a conclusion.
- Data as of 2026-09-29 (29 September 2026).
Insider trades in BCDA
as of 2026-09-23| Filed | Insider | Type | Shares | Price | Value | 90 day vs S&P |
|---|---|---|---|---|---|---|
| 23 Sep 2026 | Altman Peter | buy | 1,900 | $1.05 | $2.0K | n/a |
| 4 Sep 2026 | Altman Peter | buy | 800 | $1.09 | $872 | n/a |
| 18 Aug 2026 | Altman Peter | buy | 5,400 | $0.93 | $5.0K | n/a |
| 13 Aug 2026 | Altman Peter | buy | 1,900 | $0.92 | $1.7K | n/a |
| 29 Jul 2026 | Altman Peter | buy | 5,000 | $0.78 | $3.9K | n/a |
| 20 Jul 2026 | Altman Peter | buy | 500 | $0.83 | $415 | n/a |
| 15 Jul 2026 | Altman Peter | buy | 2,800 | $0.88 | $2.5K | n/a |
| 15 Jul 2026 | Altman Peter | buy | 1,500 | $0.86 | $1.3K | n/a |
| 10 Jul 2026 | Altman Peter | buy | 1,000 | $0.94 | $940 | n/a |
| 10 Jul 2026 | Altman Peter | buy | 5,500 | $0.97 | $5.3K | n/a |
| 10 Jul 2026 | Altman Peter | buy | 1,000 | $0.90 | $900 | n/a |
| 8 Jul 2026 | Altman Peter | buy | 5,400 | $0.96 | $5.2K | n/a |
| 24 Jun 2026 | STERTZER SIMON H | buy | 39,000 | $1.00 | $39.0K | -8.5% |
| 24 Jun 2026 | STERTZER SIMON H | buy | 70,200 | $0.92 | $64.6K | -8.5% |
| 22 Jun 2026 | Altman Peter | buy | 1,500 | $0.85 | $1.3K | +2.3% |
| 22 Jun 2026 | Altman Peter | buy | 800 | $0.96 | $768 | +2.3% |
| 9 Jun 2026 | Altman Peter | buy | 5,000 | $0.85 | $4.3K | +31.2% |
| 21 May 2026 | Altman Peter | buy | 1,500 | $0.92 | $1.4K | -1.5% |
| 21 May 2026 | Altman Peter | buy | 200 | $0.95 | $190 | -1.5% |
| 29 Apr 2026 | Altman Peter | buy | 5,000 | $1.11 | $5.5K | -34.2% |
| 22 Apr 2026 | Altman Peter | buy | 400 | $1.23 | $492 | -28.0% |
| 22 Apr 2026 | Altman Peter | buy | 600 | $1.23 | $738 | -28.0% |
| 26 Mar 2026 | Altman Peter | buy | 600 | $1.24 | $744 | -22.1% |
| 26 Mar 2026 | Altman Peter | buy | 300 | $1.22 | $366 | -22.1% |
Nothing matches that search.
Related pages
Frequently asked questions
Who has bought BCDA?
0 Congress buys by 0 members and 24 insider buys are on file. The tables on this page list every one.
Did buying BCDA after a disclosure beat the market?
Across 7 scored buys, Insiders averaged -8.7% against the S&P 500 (SPY) over the 90 days after disclosure, with 29% of them ahead of the index. That result is too few trades to draw a conclusion. A single stock is a small sample.
Sources: Congressional trades: STOCK Act disclosures, collected from CapitolTrades. Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.
Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.